Industry: Pharmaceuticals, Biotechnology
Trinity Biosystems, Inc., was founded in 2002 to commercialize a unique platform technology originally developed at the NIH/NCI. The company received its initial seed financing in 2002 in a Series A round led by Sanderling Ventures. The Founder and Chief Scientific Officer, Randy Mrsny, Ph.D., has more than 20 years experience in research and development and has worked at ALZA and Genentech. He is a recognized leader in epithelial cell biology. ( www.trinitybiosystems.com )
Trinity Biosystems , Inc.
1455 Adams Dr. Suite 1317
Menlo Park, California 94025
USA
Tel: (650) 566-0780
Fax: (650) 566-0793